COST
51
-3
MSI
69
-3
BF.B
57
7
DRI
64
4
JPM
53
-2
NUE
50
3
IR
69
-2
LMT
40
-5
LH
55
2
HRB
70
-3
AVY
54
-14
ADT
33
5
CMG
50
-6
PBI
62
2
EXC
50
-4
FMC
36
3
PSX
42
3
TXT
58
-2
PYPL
45
-2
MAR
50
3
COST
51
-3
MSI
69
-3
BF.B
57
7
DRI
64
4
JPM
53
-2
NUE
50
3
IR
69
-2
LMT
40
-5
LH
55
2
HRB
70
-3
AVY
54
-14
ADT
33
5
CMG
50
-6
PBI
62
2
EXC
50
-4
FMC
36
3
PSX
42
3
TXT
58
-2
PYPL
45
-2
MAR
50
3
Financhill
Back

Replimune Group 10K Form

Buy
58

REPL
Replimune Group

Last Price:
11.22
Seasonality Move:
10.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $4.95K
Cash Flow: $-50.84M
Price / Cash Flow: 0
Annual Sales: $6.24
Price / Book: 1.78

Profitability

EPS (TTM): -3.27000
Net Income (TTM): $-220.01M
Gross Margin: $4.95K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • The Interest Expense is -3.09% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Buy
58
Replimune Group (REPL) is a Buy

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Buy
    The current Replimune Group [REPL] share price is $11.08. The Score for REPL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.